Escalation of Cocaine Consumption in Short and Long Access Self-administration Procedures
Overview
Affiliations
Background: Escalation of consumption is a hallmark of cocaine addiction. Many animal models reveal escalation by increasing the duration of drug access (e.g., 6-24 h/day) after longer histories of self-administration. We recently developed a method that reveals escalation early post-acquisition under shorter access conditions. However, whether or not rats will escalate cocaine consumption both early post-acquisition under short access (2 h/day) conditions, and later under long access (6 h/day) conditions, has not been demonstrated.
Methods: All rats acquired cocaine self-administration (0.8 mg/kg, i.v.) under 2 h conditions, and then continued 2h self-administration for an additional 13 sessions. Then, rats were assigned either to 2 or 6h conditions, and self-administered cocaine (0.8 mg/kg, i.v.) for an additional 19 sessions. In addition, four cocaine-induced locomotor activity measurements were taken for each rat: before cocaine exposure, after non-contingent cocaine administration, and after escalation in the short and long access experimental phases.
Results: Following acquisition, rats displayed a robust escalation of intake during 2 h sessions. Rats that self-administered cocaine in continued 2h sessions exhibited stable intake, whereas rats that self-administered cocaine in 6h sessions further escalated intake. Despite the second escalation in 6h rats, cocaine-induced locomotor activity did not differ between 2 and 6h rats.
Conclusions: Escalation of cocaine self-administration can occur in the same rats both early post-acquisition, and later under long access conditions. Importantly, this early post-acquisition period provides a new opportunity to determine the mechanisms first involved in the escalation phenomenon.
Teal L, Ingram S, Bubser M, McClure E, Jones C Adv Neurobiol. 2023; 30:37-99.
PMID: 36928846 DOI: 10.1007/978-3-031-21054-9_3.
Peri-adolescent exposure to (meth)amphetamine in animal models.
Phillips T, Aldrich S Int Rev Neurobiol. 2021; 161:1-51.
PMID: 34801166 PMC: 9134876. DOI: 10.1016/bs.irn.2021.06.011.
Understanding Addiction Using Animal Models.
Kuhn B, Kalivas P, Bobadilla A Front Behav Neurosci. 2019; 13:262.
PMID: 31849622 PMC: 6895146. DOI: 10.3389/fnbeh.2019.00262.
Orsini C, Blaes S, Dragone R, Betzhold S, Finner A, Bizon J Prog Neuropsychopharmacol Biol Psychiatry. 2019; 98:109791.
PMID: 31676462 PMC: 7375467. DOI: 10.1016/j.pnpbp.2019.109791.
Ploense K, Vieira P, Bubalo L, Olivarria G, Carr A, Szumlinski K Psychopharmacology (Berl). 2017; 235(5):1347-1359.
PMID: 29234834 PMC: 5924572. DOI: 10.1007/s00213-017-4798-z.